7th Continuing Professional Development (CPD) Series: DIABETES ASIA 2008 CONFERENCE October 23 rd 26 th, 2008 Kuala Lumpur, Malaysia Conference Venue: Sunway Pyramid Convention Centre Bandar Sunway, 46150 Petaling Jaya Selangor Darul Ehsan, Malaysia Organised By: No.1, Jalan SS 3/50, 47300 Petaling Jaya Selangor Darul Ehsan, Malaysia http://www.nadidiabetes.com.my
NADI s Continuing Professional Development Series The 7th Continuing Professional Development (CPD) is expanded and upgraded as Diabetes Asia 2008 Conference. The Conference shall have three tracks: Track 1: Diabetes Care in practice Track 2: Advances in Diabetology Track 3: Free Paper Presentation Objectives of the Conference The Continuing Professional Development (CPD) Series as Diabetes Asia 2008 Conference aims to help improve management of diabetes by healthcare professionals by emphasising up-to-date and practical aspects of diabetes care. Participants are expected to be able to: appreciate recent advances and the practical aspects of diabetes care. understand ways of ensuring early diagnosis and optimal management so as to achieve good control of diabetes, complications and associated diseases. apply knowledge gained during the Conference to further improve care for persons with diabetes in the community. Who Should Attend Healthcare professionals responsible for managing those with diabetes including: Medical and Surgical Specialists General Practitioners Medical and Health Officers Trainee Lecturers Pharmacists Nursing Practitioners Diabetes Educators The Conference will emphasise on recent advances and current practical management of diabetes, its complications and related diseases
Organising Committee Patron Tun Dr. Mahathir Mohamad Advisors Tan Sri Dato Dr. Abu Bakar Suleiman Professor Dato Khalid Abdul Kadir Professor Dato Anuar Zaini Md Zain Chairman Professor Dato Mustaffa Embong Secretary Dato Dr. Nor Aini Abu Bakar Treasurer Ms. Rosmawati Yusoff Conference Speakers Sub Committee Chairpersons Scientific Professor Dato Mafauzy Mohamed (Chairman) Professor Dato Wan Mohamad Wan Bebakar Professor Nor Azmi Kamaruddin Professor Rokiah Pendek Assoc. Professor Malik Mumtaz Dr. Zanariah Hussein Fund Raising & Exhibition Ms. Yasmin Rahimi Audiovisual Mr. Zamri Husin Social Programmes Ms. Azizah Mohd Noor Special Functions S/N Kee Poh Siew Events Coordinator Ms. Alamiah Zakaria International Faculty: 1. Professor Harold E. Lebovitz, USA 5. Professor David Owens, United Kingdom 2. Professor Thep Himathongkam, Thailand 6. Professor Low-Tone Ho, Taiwan 3. Professor Stephen M. Twigg, Australia 7. Professor Massimo Massi-Benedetti, Italy 4. Professor Clive S. Cockram, Hong Kong 8. Professor Sri Hartini K. S. Kariadi, Indonesia Local Faculty: 1. Professor Puan Sri Datin Nafisah Adeeb, HUKM 17. Assoc. Professor Malik Mumtaz, PMC 2. Professor Dato Anuar Zaini Md Zain, MUM 18. Assoc. Professor Norlaila Mustaffa, HUKM 3. Professor Dato Khalid Abdul Kadir, MUM 19. Assoc. Professor Paul Jambunathan, MUM 4. Professor Dato Khalid Yusoff, UiTM 20. Datin Dr. Liew Yin Mei, NHF 5. Professor Dato Mafauzy Mohamed, USM 21. Dato Dr. Azhari Rosman, IJN 6. Professor Dato Mustaffa Embong, USM 22. Dato Dr. Rosli Mohd Ali, IJN 7. Professor Dato Nik Mohd Nasri Nik Ismail, USIM 23. Dr. Zanariah Hussein, MOH 8. Professor Dato Wan Mohamad Wan Bebakar, USM 24. Dr. Faridah Ismail, GIMC 9. Professor Datin Norella Kong, HUKM 25. Dr. G. R. Letchuman, MOH 10. Professor Amir Sharifuddin Mohd Khir, PMC 26. Dr. Hew Fen Lee, SJMC 11. Professor Che Muhaya Hj. Muhamad, PCMC 27. Dr. Nor Azizah Aziz, MOH 12. Professor Fatimah Harun, UM 28. Dr. Mohamed Badrulnizam Long Bidin, MOH 13. Professor Nor Azmi Kamaruddin, HUKM 29. Dr. Siti Harnida Md Isa, AH 14. Professor Rabindarjeet Singh, NSC 30. Ms. Shanaz Mawji, SJMC 15. Professor Rokiah Pendek, UM 31. Ms. Tan Yoke Hwa, MOH 16. Professor Wu Loo Ling, HUKM
Conference Outline* 23 Oct 2008 24 Oct 2008 25 Oct 2008 26 Oct 2008 Thursday Friday Saturday Sunday (0700 1000) Registration (1000 1200) Pre-Congress (1200 1400) Lunch 1 (0700 0830) Breakfast 1 (0700 0830) (0700 0830) Breakfast 2 Breakfast 3 (0830 1000) (0830 1000) (0830 1000) Plenary 1 Plenary 3 Plenary 5 Plenary 2 Plenary 4 Plenary 6 Break (1000-1030) (1030 1230) 3 (1230 1430) Lunch 2A Lunch 2B (1030 1300) 6 (1030 1300) 9 (1300 1430) Lunch 3A (1300 1430) Lunch 4 Lunch 3B (1400 1600) 1 (1630 1800) 2 (1430 1600) (1430 1600) Experts Case Discussion Experts Case Discussion 1 2 3 4 Free Paper Presentation Free Paper Presentation 1 2 3 4 5 6 Break (1600 1630) (1630 1800) (1630 1800) 4 (1800 2000) Free Time 5 7 8 (1430 1600) 10 (2000 2200) Dinner 1 *Subject to change (2000 2200) Dinner 2 (2000 2200) Dinner 3 Scientific Programme* Plenary 1 : Diabetes Epidemic Fighting a Losing Battle? Speaker : Professor Clive S. Cockram, Hong Kong Plenary 2 : Postprandial Hyperglycaemia: Key to Early Diagnosis of Diabetes & Prevention of Cardiovascular Disease Speaker : Professor Thep Himathongkam, Thailand Plenary 3 : Controversies in the Current Management of Type 2 Diabetes Speaker : Professor Harold E. Lebovitz, USA Plenary 4 : Diabetes Education: Taiwan Experience Speaker : Professor Low-Tone Ho, Taiwan Plenary 5 : The Potential of Reversing Beta Cell Failure in T2DM Speaker : Professor Massimo Massi-Benedetti, Italy Plenary 6 : Diabetes Technologies: Pumps and Monitors Speaker : Professor Stephen M. Twigg, Australia
1: Paediatric Diabetes 1. Preventing type 1? 2. Young diabetics: type 1, 2 or 1½? 3. Insulin use in type 1: The What and How 2: Prevention & Early Detection 1. Prevention of type 2 diabetes: Beyond lifestyle modifications 2. Early detection and prevention of retinopathy in primary care 3. Should microalbuminuria be treated? 3: (Servier M sia SB): Diabetes & Cardiovascular Prevention 1. Why diabetics more prone to CVD diseases 2. IHD in diabetics: implications and management 3. Diabetes and Cardiovascular Disease: The Need to ADVANCE 4: (Merck Serono): Oral Hypoglycaemic Agents 1. Types and Mechanism of action of OHAs 2. Combination and Once-daily: A case for Glucovance 3. New Classes of Therapeutic Agents in Development 5: Non-pharmacological Management 1. Low glycaemic index - does it matter? 2. Effects of exercise on skeletal muscle - Improving insulin resistance 3. Diabetes Education - How to motivate patients to comply 6: (Solvay Pharma M sia): Managing CVD Risk Factors in Diabetics 1. Updates of Residual Risks in Diabetes 2. When should BP be treated: Current concepts 3. Non traditional risk factors: should these be routinely assessed? 7: Emerging Therapies for Diabetes 1. Incretin mimetics and enhancers 2. A case for Na-Glucose transporter inhibitors? 3. Bitter gourd and other herbal therapies 8: Helping Diabetics to Cope Better 1. When psychological counselling is necessary 2. Practical care of diabetic foot 3. SMBG monitoring 9: Diabetes & Pregnancy 1. Hyperglycaemia: Effects on the foetus 2. Optimal management of gestational diabetes 3. Which insulin for diabetes in pregnancy? 10: In-patient Care of Hyperglycaemia 1. ICU/CCU Patients: Is tight glycaemic control important? 2. In-patient Insulin Use: Continuous or intermittent, IV or SC? 3. In-patients glycaemic targets and monitoring Lunch 1: (subject to confirmation) Lunch 2A: Novo Nordisk Pharma (M) Sdn Bhd - Ideal Start and Easy Intensification with NovoMix 30 Lunch 2B: (subject to confirmation) Lunch 3A: Eli Lilly (M) Sdn Bhd - Scientific Overview of Exanatide Lunch 3B: GlaxoSmithKline Pharmaceutical Sdn Bhd Lunch 4: (subject to confirmation) Experts Case Discussion 1: Management of Type 1 Diabetes Experts Case Discussion 2: Management of Diabetes During Pregnancy Experts Case Discussion 3: Management of Uncontrolled Type 2 Experts Case Discussion 4: Management of CVD Risk Factors in Diabetics * Subject to change Free paper presentation Participants are encouraged to submit free papers for oral or poster presentation. Free paper presentation is limited only to aspects relating to the practical management of diabetes, its complications and co-morbidities. Please refer to the attached paper Call for Free Paper Abstracts for instructions. Closing date for free paper abstract submission is 31st July 2008.
Registration & Fees Registration form is enclosed with this FINAL ANNOUNCEMENT. Completed form must be returned with the registration fee to the Conference Secretariat by mail or fax. Registration fee covers admission to all NADI Conference sessions and trade exhibition, Conference materials, Conference lunches and tea/coffee breaks. The fees are as follows: Overseas Delegates Malaysian Delegates Registration Early Bird Before 31st July 2008 After 31 st July 2008 Delegate USD400 USD500 Registration Early Bird Before 31st July 2008 After 31 st July 2008 Delegate RM650 RM800 Postgraduate Student* USD350 USD450 Paramedic / Allied Health USD350 USD450 Postgraduate Student* RM550 RM700 Paramedic / Allied Health RM500 RM700 * Official endorsement from institution is required. Please register early to enjoy Early Bird discount. Payment should be made payable to: National Diabetes Institute Accommodation Special room rates have been arranged for the Conference participants from October 23rd 26th, 2007 at the following hotels: Sunway Lagoon Resort Hotel Sun Inns Hotel Sheraton Subang - Tower - Sun Inns Menteri Holiday Villa Subang - Pyramid Tower - Sun Inns Lagoon Summit Hotel Participants are advised to reserve their hotel accommodation early, DIRECTLY with the hotel of their choice. Please specify that you wish to book as a participant of the National Diabetes Institute Conference in order to qualify for the special rates offered. Please refer to the accompanying leaflet for details. For further information and updates regarding the conference, please contact: The Secretariat (Attention: Ms. Azizah / Ms. Rosmawati / Ms. Kee) National Diabetes Institute (NADI) No. 1, Jalan SS 3/50, 47300 Petaling Jaya, Selangor, MALAYSIA Tel: +603-7876 1676 / 7876 1677 Fax: +603-7876 1679 Email: nadi@myjaring.net About the National Diabetes Institute (NADI) The National Diabetes Institute (NADI) is established to provide a dedicated and comprehensive service for diabetics, to prevent and control diabetes and its complications. NADI is a non profit organisation registered as a company limited by guarantee. It is managed by a Board of Trustees comprising representatives from the Malaysia Endocrine and Metabolic Society (MEMS), Malaysian Diabetes Association (PDM), Ministry of Health (MoH), Elected and Founding members. The main objectives of NADI are: to be a National Diabetes Education Resource Centre for the country to create and maintain a National Diabetes Registry to establish and run a comprehensive health facility including a National Diabetes Hospital for the management of diabetes and its complications to coordinate and conduct research in diabetes and related conditions to be the national reference as well as the national coordinating centre for diabetes in Malaysia in respect to statistics, education, management, research, policy and planning on diabetes and associated diseases NADI Office: No. 1, Jalan SS 3/50, 47300 Petaling Jaya, Selangor, MALAYSIA Tel: +603-7876 1676 / 7876 1677 Fax: +603-7876 1679 Email: nadi@myjaring.net Website: www.nadidiabetes.com.my